Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
$0.09
-1.1%
$0.15
$0.05
$0.81
N/AN/A2,406 shs110 shs
CF Acquisition Corp. VIII stock logo
CFFEW
CF Acquisition Corp. VIII
$0.04
$0.05
$0.01
$0.32
N/AN/A18,321 shsN/A
DKDCW
Data Knights Acquisition
$0.03
+0.3%
$0.04
$0.01
$0.09
N/AN/A56,534 shs4,011 shs
SQLLW
SeqLL
$0.00
$0.00
$0.00
$0.01
N/AN/A35,059 shsN/A
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
-13.50%-13.50%-40.75%-69.54%-58.81%
CF Acquisition Corp. VIII stock logo
CFFEW
CF Acquisition Corp. VIII
-22.22%+1.25%-32.33%-41.24%+23.40%
DKDCW
Data Knights Acquisition
-16.62%-8.80%-16.62%-17.72%-17.72%
SQLLW
SeqLL
0.00%0.00%+8.33%+8.33%+41.30%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
$0.09
-1.1%
$0.15
$0.05
$0.81
N/AN/A2,406 shs110 shs
CF Acquisition Corp. VIII stock logo
CFFEW
CF Acquisition Corp. VIII
$0.04
$0.05
$0.01
$0.32
N/AN/A18,321 shsN/A
DKDCW
Data Knights Acquisition
$0.03
+0.3%
$0.04
$0.01
$0.09
N/AN/A56,534 shs4,011 shs
SQLLW
SeqLL
$0.00
$0.00
$0.00
$0.01
N/AN/A35,059 shsN/A
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
-13.50%-13.50%-40.75%-69.54%-58.81%
CF Acquisition Corp. VIII stock logo
CFFEW
CF Acquisition Corp. VIII
-22.22%+1.25%-32.33%-41.24%+23.40%
DKDCW
Data Knights Acquisition
-16.62%-8.80%-16.62%-17.72%-17.72%
SQLLW
SeqLL
0.00%0.00%+8.33%+8.33%+41.30%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
0.00
N/AN/AN/A
CF Acquisition Corp. VIII stock logo
CFFEW
CF Acquisition Corp. VIII
0.00
N/AN/AN/A
DKDCW
Data Knights Acquisition
0.00
N/AN/AN/A
SQLLW
SeqLL
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
$5.61MN/AN/AN/AN/AN/A
CF Acquisition Corp. VIII stock logo
CFFEW
CF Acquisition Corp. VIII
N/AN/AN/AN/AN/AN/A
DKDCW
Data Knights Acquisition
N/AN/AN/AN/AN/AN/A
SQLLW
SeqLL
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
N/AN/AN/AN/AN/AN/AN/AN/A8/19/2026 (Estimated)
CF Acquisition Corp. VIII stock logo
CFFEW
CF Acquisition Corp. VIII
N/AN/AN/AN/AN/AN/AN/AN/AN/A
DKDCW
Data Knights Acquisition
N/AN/AN/AN/AN/AN/AN/AN/AN/A
SQLLW
SeqLL
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest SQLLW, BIAFW, CFFEW, and DKDCW Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/19/2026N/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
-$2.10N/AN/AN/A$1.70 millionN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
N/AN/AN/AN/AN/A
CF Acquisition Corp. VIII stock logo
CFFEW
CF Acquisition Corp. VIII
N/AN/AN/AN/AN/A
DKDCW
Data Knights Acquisition
N/AN/AN/AN/AN/A
SQLLW
SeqLL
N/AN/AN/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
10N/AN/ANot Optionable
CF Acquisition Corp. VIII stock logo
CFFEW
CF Acquisition Corp. VIII
3N/AN/ANot Optionable
DKDCW
Data Knights Acquisition
2N/AN/ANot Optionable
SQLLW
SeqLL
7N/AN/ANot Optionable

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

Media Sentiment Over Time

bioAffinity Technologies stock logo

bioAffinity Technologies NASDAQ:BIAFW

$0.09 0.00 (-1.14%)
Closing price 07/24/2026 07:00 AM Eastern
Extended Trading
$0.09 0.00 (0.00%)
As of 07/24/2026 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.

CF Acquisition Corp. VIII stock logo

CF Acquisition Corp. VIII NASDAQ:CFFEW

$0.04 0.00 (0.00%)
As of 07/24/2026

XBP Europe Holdings, Inc. provides bills, payments, and related solutions and services in France, Germany, the United Kingdom, Sweden, and internationally. It offers XBP platform that provides secure messaging services; request to pay solutions; enterprise information management solutions; digital mailroom and records digitization solutions; business process management and intelligent workflow automation solutions; integrated communications solution; banking and financial industry solutions and services; cross-border payments; digitization of checks; confirmation of payee; and mortgage and loan management solutions. The company is based in New York, New York. XBP Europe Holdings, Inc operates as a subsidiary of Exela Technologies, Inc.

Data Knights Acquisition NASDAQ:DKDCW

$0.03 +0.00 (+0.32%)
As of 07/24/2026

Data Knights Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in the data centers and internet technology sectors. The company was incorporated in 2021 and is based in Chessington, the United Kingdom.

SeqLL NASDAQ:SQLLW

$0.0033 0.00 (0.00%)
As of 07/23/2026

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. It focus on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provide solutions for various applications, such as biomarker discovery and diagnostic assay developments including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justice's Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and research collaboration with True Bearing Diagnostics, Inc. performing tSMS on whole-blood RNA to identify transcripts associated with coronary artery disease. Further, it has collaboration agreement with The Bernstein Laboratory to address fundamental questions in chromatin biology and epigenetic regulation; The Ting Laboratory; The Jackson Laboratory for Genomic Medicine assisting in the development of new methods for chromatin interaction analysis in single nuclei, with single-molecule resolution; Weizmann Institute of Science for developed and applied innovative single-molecule technologies; and Tetracore, Inc. to provide with tSMS systems and onsite support. The company was founded in 2013 and is headquartered in Billerica, Massachusetts.